Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy

被引：0
|
作者：
Hesketh, P. J.
Sanz-Altamira, P.
Bushey, J.
Malek, K.
Insalaco, L.
Hesketh, A. M.
机构：
[1] Caritas St Elizabeths Med Ctr, Boston, MA USA
[2] Caritas Holy Family Hosp, Methuen, MA USA
[3] Caritas Good Samaritan Med Ctr, Brockton, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.9645
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9645
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy
    Hesketh, Paul J.
    Sanz-Altamira, Pedro
    Bushey, Julie
    Hesketh, Ann M.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (05) : 1043 - 1047
  • [2] Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy
    Paul J. Hesketh
    Pedro Sanz-Altamira
    Julie Bushey
    Ann M. Hesketh
    Supportive Care in Cancer, 2012, 20 : 1043 - 1047
  • [3] Prospective evaluation for chemotherapy-induced nausea and vomiting in colorectal cancer receiving oxaliplatin-based chemotherapy of moderate emetic risk
    Shimokawa, M.
    Hayashi, T.
    Kogawa, T.
    Matsui, R.
    Suzuki, K.
    Saeki, T.
    Aiba, K.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27 : 17 - 17
  • [4] Prevalence of Delayed Nausea and/or Vomiting in Patients Treated With Oxaliplatin-Based Regimens for Colorectal Cancer
    Fleishman, Stewart B.
    Mahajan, Divya
    Rosenwald, Victoria
    Nugent, Ann V.
    Mirzoyev, Tahir
    JOURNAL OF ONCOLOGY PRACTICE, 2012, 8 (03) : 136 - 140
  • [5] Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy
    Hesketh, Paul J.
    Bosnjak, Snezana M.
    Nikolic, Vlada
    Rapoport, Bernardo
    SUPPORTIVE CARE IN CANCER, 2011, 19 (12) : 2063 - 2066
  • [6] Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy
    Paul J. Hesketh
    Snezana M. Bosnjak
    Vlada Nikolic
    Bernardo Rapoport
    Supportive Care in Cancer, 2011, 19
  • [7] Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea
    Hiroyoshi Takemoto
    Junichi Nishimura
    Takamichi Komori
    Ho Min Kim
    Hirofumi Ota
    Rei Suzuki
    Masakazu Ikenaga
    Masataka Ikeda
    Hirofumi Yamamoto
    Taroh Satoh
    Taishi Hata
    Ichiro Takemasa
    Tsunekazu Mizushima
    Yuichirou Doki
    Masaki Mori
    International Journal of Clinical Oncology, 2017, 22 : 88 - 95
  • [8] Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea
    Takemoto, Hiroyoshi
    Nishimura, Junichi
    Komori, Takamichi
    Kim, Ho Min
    Ota, Hirofumi
    Suzuki, Rei
    Ikenaga, Masakazu
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Satoh, Taroh
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Doki, Yuichirou
    Mori, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (01) : 88 - 95
  • [9] Oxaliplatin for colorectal cancer: Prevalence of delayed nausea and/or vomiting
    Fleishman, S. B.
    Gorospe, V. E.
    Rosenwald, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] A pooled analysis evaluating the combination antiemetic therapy on chemotherapy-induced nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy of moderate emetic risk
    Shimokawa, M.
    Kogawa, T.
    Nishimura, J.
    Satoh, T.
    Nakata, K.
    Hayashi, T.
    Matsui, R.
    Aiba, K.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2017, 28
12345